Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Functional outcome was assessed using various neurological scoring systems across the included studies
Commonly used in hormone-dependent conditions.Therapeutic Category: GnRH Agonist / Hormonal Therapy Mechanism of
doi: 10.3389/fnut.2024.1509577 Received 11 October 2024 Accepted 02 December 2024 Published 16 December 2024 Volume 11 - 2024 Edited by Shaohua Qi, Houston Methodist Research Institute, United States Reviewed by Ying-yuan Lu, Peking University, China Ma Ying, China Academy of Chinese Medical Sciences, China Kexin Gai, Northwestern University, United States Ting Wu, University of Texas Health Science Center at Houston, United States Updates Copyright 2024 Xing, Du, Li, Wang, Zhang, Gao, Han, Sun, Sun, Du, Hu, Yu and Qin
Risk of Bias assessment of the included articles was conducted using the Risk of Bias version 2 (RoB2) tool ( Statistical analyses We performed all meta-analyses using RevMan (version 5.4, Cochrane Collaboration)
US$ 20.01
US$ 22.72
US$ 21.28
US$ 29.39
